Company Profile

Thermedical Inc (AKA: Engineering Partnership~EP LTDD~EP Limited~3P LT)
Profile last edited on: 6/13/21      CAGE: 47LG4      UEI: L447XJXMJ7L5

Business Identifier: Thermal ablation systems to treat previously untreatable cancer and cardiac arrhythmias
Year Founded
1995
First Award
1995
Latest Award
2018
Program Status
Active
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

150 Bear Hill Road
Waltham, MA 02451
   (781) 373-3688
   info@thermedical.com
   www.thermedical.com
Location: Single
Congr. District: 05
County: Middlesex

Public Profile

Formerly doing business as EP Limited and having previously had ties to the MIT Hyperthermia Center, Thermedical is a long established medical device company leveraging competencies in biologic heat transfer to tdevelop andsupport a revolutionary approach to RF tissue ablation. TUsing Saline-Enhanced Radio Frequency (SERF) energy, the firm's Thermedical Ablation System has been designed to overcome the challenges of traditional ablation tools and the creation of the large lesions that are required to treat certain medical conditions. The firm is focused on the treatment and cure of Ventricular Tachycardia (VT), an irregular heartbeat that can lead to sudden cardiac arrest, and the treatment of soft tissue conditions, including potentially liver, kidney, lung and uterine tumors. The Thermedical Ablation System is 510(k) cleared for the coagulation and ablation of soft tissue during percutaneous, laparoscopic and intraoperative surgical procedures.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
10-14
Revenue Range
1M-1.5M
VC funded?
Yes
Public/Private
Privately Held
Stock Info
----
IP Holdings
25-49

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2018 2 NIH $2,833,988
Project Title: Eliminating Ventricular Tachycardia: First in Human Clinical Trial Using the Durablate™ Catheter
2010 2 NIH $4,797,200
Project Title: Novel Catheter for Treatment of Ventricular Tachycardia
2008 2 NIH $4,060,533
Project Title: Saline Enhanced Radiofrequency Ablation For Liver Tumors
2007 2 NIH $973,396
Project Title: An Ambulatory Lordosimeter for Posture Control
2000 1 NIH $100,012
Project Title: Development Of An Open-Source Arrhythmia Detector

Key People / Management

  Michael G Curley -- President & Co-founder

  Trena Depel -- VP Clinical, Regulatory and Quality

  Patrick S Hamilton -- Founding PartnerVP of Engineering

  Samuel H Maslak -- Chairman of Board